MedTrace Logo

An Intervention to Increase Engagement With Hypertension Care for American Indian Patients

NCT04414982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 339

Last updated 2020-09-01

No results posted yet for this study

Summary

The objective of this study is to reduce the effects of stereotype threat on the adherence of American Indian/Alaska Native patients with hypertension.

The specific aims of this study, which employs a values affirmation intervention, are to:

1. Compare the effects of the values-affirmation exercise with a control exercise in AI/AN patients with hypertension.
2. Compare the effects of the values-affirmation exercise in AI/AN patients with its effects in white patients.

Conditions

Interventions

BEHAVIORAL

Intervention Values Affirmation

Participants are asked to circle the two or three values that are MOST important to them. Next, participants are asked to think about times when the values chosen might be important to THEMSELVES and then write a few sentences to describe when and why they might be important.

BEHAVIORAL

Control Values Affirmation

Participants are asked to circle the two or three items that are LEAST important to them. Next, participants are asked to think about times when the values chosen might be important to SOMEONE ELSE and then write a few sentences to describe when and why they might be important.

Sponsors & Collaborators

  • American Heart Association

    collaborator OTHER

  • University of Colorado Centers for American Indian and Alaska Native Health

    collaborator UNKNOWN

  • Denver Health and Hospital Authority

    collaborator OTHER

  • Denver Indian Health and Family Services

    collaborator UNKNOWN

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Ed Havranek, MD · University of Colorad, Denver

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04414982 on ClinicalTrials.gov